CN105120839B - 可注射长效局麻药半固体制剂及其组成成分 - Google Patents

可注射长效局麻药半固体制剂及其组成成分 Download PDF

Info

Publication number
CN105120839B
CN105120839B CN201480011256.0A CN201480011256A CN105120839B CN 105120839 B CN105120839 B CN 105120839B CN 201480011256 A CN201480011256 A CN 201480011256A CN 105120839 B CN105120839 B CN 105120839B
Authority
CN
China
Prior art keywords
semi
pharmaceutical composition
solid
bupivacaine
semisolid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480011256.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN105120839A (zh
Inventor
沈惠荣
甘娜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huzhou Huizhong Jishi Biotechnology Co ltd
Original Assignee
Huzhou Huizhong Jishi Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huzhou Huizhong Jishi Biotechnology Co ltd filed Critical Huzhou Huizhong Jishi Biotechnology Co ltd
Publication of CN105120839A publication Critical patent/CN105120839A/zh
Application granted granted Critical
Publication of CN105120839B publication Critical patent/CN105120839B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201480011256.0A 2013-02-28 2014-02-28 可注射长效局麻药半固体制剂及其组成成分 Active CN105120839B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361771011P 2013-02-28 2013-02-28
US61/771,011 2013-02-28
PCT/US2014/019704 WO2014134586A2 (en) 2013-02-28 2014-02-28 Injectable long-acting local anesthetic semi-solid formulations and its compostions

Publications (2)

Publication Number Publication Date
CN105120839A CN105120839A (zh) 2015-12-02
CN105120839B true CN105120839B (zh) 2020-07-28

Family

ID=50288331

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480011256.0A Active CN105120839B (zh) 2013-02-28 2014-02-28 可注射长效局麻药半固体制剂及其组成成分

Country Status (8)

Country Link
US (1) US10500281B2 (enExample)
EP (1) EP2961380B1 (enExample)
JP (1) JP6363115B2 (enExample)
KR (1) KR101768843B1 (enExample)
CN (1) CN105120839B (enExample)
AU (1) AU2014223993B2 (enExample)
CA (1) CA2903020C (enExample)
WO (1) WO2014134586A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9849180B2 (en) 2014-09-15 2017-12-26 Hui Rong Shen Long-acting semi-solid lipid formulations
EP2961380B1 (en) 2013-02-28 2020-04-08 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compositions
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
US20170296484A1 (en) * 2015-11-23 2017-10-19 Grace Therapeutics Llc Topical Film-Forming Spray
EP3452119A1 (en) * 2016-05-02 2019-03-13 The General Hospital Corporation Implant surfaces for pain control
EP3558279A4 (en) * 2016-12-26 2020-12-02 Cellix Bio Private Limited COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN
JP7046396B2 (ja) * 2017-12-06 2022-04-04 湖州惠中濟世生物科技有限公司 注射可能な長時間作用性局所麻酔薬半固形製剤
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
CN113262302B (zh) * 2020-02-17 2022-12-09 湖州惠中济世生物科技有限公司 可注射长效半固体凝胶制剂
EP4284272A4 (en) * 2021-01-29 2024-12-25 Insitu Biologics, Inc. COMPOSITIONS AND METHODS OF SUSTAINED TREATMENT OF PAIN
JP2023027715A (ja) * 2021-08-17 2023-03-02 株式会社カネカ 医薬組成物、及び貼付剤

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458388A (zh) * 2009-06-11 2012-05-16 光治疗Asa公司 半固体组合物及药物制品
CN102858374A (zh) * 2010-04-01 2013-01-02 帕玛内斯特公司 热胶凝麻醉剂组合物
CN102869344A (zh) * 2010-04-01 2013-01-09 帕玛内斯特公司 局部麻醉剂的生物黏附性组合物
CN102892408A (zh) * 2010-04-01 2013-01-23 帕玛内斯特公司 适于局部麻醉剂的无水药物组合物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775659A (en) * 1985-08-19 1988-10-04 Eli Lilly And Company Injectable semi-solid formulations
SE9200952D0 (sv) 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
US5700485A (en) 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
JPH08143449A (ja) * 1994-11-17 1996-06-04 Lederle Japan Ltd 徐放性局所麻酔用注射剤
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
CN1156961A (zh) 1995-06-09 1997-08-13 欧罗赛铁克股份有限公司 产生长效局部麻醉的制剂和方法
GB9610862D0 (en) * 1996-05-23 1996-07-31 Evans Brian K Pharmaceutical products
ES2373861T3 (es) 1997-09-18 2012-02-09 Pacira Pharmaceuticals, Inc. Composiciones anestésicas liposomiales de liberación sostenida.
AU781682B2 (en) * 2000-03-20 2005-06-09 Zoetis Services Llc Sustained-release compositions for parenteral administration
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
GB0015617D0 (en) 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
DE10033059A1 (de) * 2000-07-07 2002-01-31 Wacker Chemie Gmbh Komplexe aus gamma-Cyclodextrin und Benzocain, Verfahren zu ihrer Herstellung und ihre Verwendung
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20040001889A1 (en) * 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US20070184089A1 (en) * 2002-07-15 2007-08-09 Alcon, Inc. Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US7666914B2 (en) 2004-06-03 2010-02-23 Richlin David M Topical preparation and method for transdermal delivery and localization of therapeutic agents
GB0524958D0 (en) * 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents
PL3085363T3 (pl) 2007-03-28 2019-08-30 Innocoll Pharmaceuticals Limited Urządzenie dostarczające lek dla zapewnienia miejscowej analgezji, miejscowego znieczulenia lub blokady nerwowej
WO2011075623A1 (en) 2009-12-18 2011-06-23 Latitude Pharmaceuticals, Inc. One - phase gel compos ition compri s ing phos pholi pids
EP2961380B1 (en) 2013-02-28 2020-04-08 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compositions
DK3134068T3 (da) 2014-04-21 2021-10-04 Heron Therapeutics Inc Langtidsvirkende polymerafgivelsessystemer

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458388A (zh) * 2009-06-11 2012-05-16 光治疗Asa公司 半固体组合物及药物制品
CN102858374A (zh) * 2010-04-01 2013-01-02 帕玛内斯特公司 热胶凝麻醉剂组合物
CN102869344A (zh) * 2010-04-01 2013-01-09 帕玛内斯特公司 局部麻醉剂的生物黏附性组合物
CN102892408A (zh) * 2010-04-01 2013-01-23 帕玛内斯特公司 适于局部麻醉剂的无水药物组合物

Also Published As

Publication number Publication date
EP2961380B1 (en) 2020-04-08
US10500281B2 (en) 2019-12-10
AU2014223993A1 (en) 2015-10-15
CN105120839A (zh) 2015-12-02
US20150366967A1 (en) 2015-12-24
JP2016510041A (ja) 2016-04-04
AU2014223993B2 (en) 2016-09-08
EP2961380A2 (en) 2016-01-06
WO2014134586A2 (en) 2014-09-04
CA2903020A1 (en) 2014-09-04
KR20150126375A (ko) 2015-11-11
KR101768843B1 (ko) 2017-08-17
JP6363115B2 (ja) 2018-07-25
CA2903020C (en) 2019-06-18
WO2014134586A3 (en) 2014-11-06

Similar Documents

Publication Publication Date Title
CN105120839B (zh) 可注射长效局麻药半固体制剂及其组成成分
US10206876B2 (en) Depot formulations of a local anesthetic and methods for preparation thereof
KR102098980B1 (ko) 오피오이드 제형
JP6417327B2 (ja) オピオイド製剤
KR20170072237A (ko) 주사가능한 부프레노르핀 제형
US6113937A (en) Sustained release sufentanil compositions
US10561606B2 (en) Injectable long-acting local anesthetic semi-solid gel formulations
EP3720420B1 (en) Injectable long-acting local anesthetic semi-solid gel formulations
CN113262302B (zh) 可注射长效半固体凝胶制剂
JP7767636B2 (ja) 疼痛治療用医薬組成物
WO2025015222A2 (en) Pharmaceutical compositions
AU712333C (en) Sustained release sufentanil compositions

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20200511

Address after: No.1366, Hongfeng Road, Huzhou City, Zhejiang Province

Applicant after: Huzhou Huizhong Jishi Biotechnology Co., Ltd

Address before: Washington State

Applicant before: MIRA PHARMA Corp.

GR01 Patent grant
GR01 Patent grant